192 related articles for article (PubMed ID: 17823260)
1. Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin.
Paquette J; Bessette B; Ledru E; Deal C
Endocrinology; 2007 Dec; 148(12):6007-18. PubMed ID: 17823260
[TBL] [Abstract][Full Text] [Related]
2. Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein.
Grassadonia A; Tinari N; Fiorentino B; Nakazato M; Chung HK; Giuliani C; Napolitano G; Iacobelli S; Howcroft TK; Singer DS; Kohn LD;
Endocrinology; 2007 Jul; 148(7):3507-17. PubMed ID: 17446190
[TBL] [Abstract][Full Text] [Related]
3. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
Barber MC; Vallance AJ; Kennedy HT; Travers MT
Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the promoter of 1A6/DRIM, a novel cancer-related gene and identification of its transcriptional activator.
Xing X; Du X; Lu Z; Ning T; Su X; Ke Y
Gene; 2005 Jan; 344():161-9. PubMed ID: 15656982
[TBL] [Abstract][Full Text] [Related]
7. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
8. Transcription of cathepsin B in glioma cells: regulation by an E-box adjacent to the transcription initiation site.
Yan S; Jane DT; Dufresne MJ; Sloane BF
Biol Chem; 2003; 384(10-11):1421-7. PubMed ID: 14669984
[TBL] [Abstract][Full Text] [Related]
9. CpG methylation at the USF-binding site is important for the liver-specific transcription of the chipmunk HP-27 gene.
Fujii G; Nakamura Y; Tsukamoto D; Ito M; Shiba T; Takamatsu N
Biochem J; 2006 Apr; 395(1):203-9. PubMed ID: 16396632
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
11. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
Allen RR; Qi L; Higgins PJ
J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
13. Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter.
Xing W; Archer TK
Mol Endocrinol; 1998 Sep; 12(9):1310-21. PubMed ID: 9731700
[TBL] [Abstract][Full Text] [Related]
14. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.
Goswami R; Lacson R; Yang E; Sam R; Unterman T
Endocrinology; 1994 Feb; 134(2):736-43. PubMed ID: 7507835
[TBL] [Abstract][Full Text] [Related]
16. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
[TBL] [Abstract][Full Text] [Related]
17. Identification of cis-elements mediating the stimulation of rat insulin-like growth factor-binding protein-1 promoter activity by dexamethasone, cyclic adenosine 3',5'-monophosphate, and phorbol esters, and inhibition by insulin.
Suh DS; Ooi GT; Rechler MM
Mol Endocrinol; 1994 Jun; 8(6):794-805. PubMed ID: 7523864
[TBL] [Abstract][Full Text] [Related]
18. Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box.
Coulson JM; Edgson JL; Marshall-Jones ZV; Mulgrew R; Quinn JP; Woll PJ
Biochem J; 2003 Feb; 369(Pt 3):549-61. PubMed ID: 12403649
[TBL] [Abstract][Full Text] [Related]
19. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the human Cdc2l2 gene promoter.
Feng Y; Goulet AC; Nelson MA
Gene; 2004 Apr; 330():75-84. PubMed ID: 15087126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
